Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands

For patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), chemotherapy can prolong life and alleviate symptoms. However, expected gains may be small, not necessarily outweighing considerable toxicity and high costs. Treatment choice is to a large extent...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Linden, Naomi, Buter, Jan, Pescott, Chris P., Lalisang, Roy I., de Boer, Jan Paul, de Graeff, Alexander, van Herpen, Carla M. L., Baatenburg de Jong, Robert J., Uyl-de Groot, Carin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Head and Neck
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733133/
https://www.ncbi.nlm.nih.gov/pubmed/25876000
http://dx.doi.org/10.1007/s00405-015-3495-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733133/
https://www.ncbi.nlm.nih.gov/pubmed/25876000
http://dx.doi.org/10.1007/s00405-015-3495-y

Ejemplares similares